BRPI0915696A2 - vacina de rotavírus estável, secada, composições e processo para preparação da mesma - Google Patents

vacina de rotavírus estável, secada, composições e processo para preparação da mesma

Info

Publication number
BRPI0915696A2
BRPI0915696A2 BRPI0915696A BRPI0915696A BRPI0915696A2 BR PI0915696 A2 BRPI0915696 A2 BR PI0915696A2 BR PI0915696 A BRPI0915696 A BR PI0915696A BR PI0915696 A BRPI0915696 A BR PI0915696A BR PI0915696 A2 BRPI0915696 A2 BR PI0915696A2
Authority
BR
Brazil
Prior art keywords
compositions
stable
preparing same
rotavirus vaccine
dried rotavirus
Prior art date
Application number
BRPI0915696A
Other languages
English (en)
Inventor
Jagdish K Zade
Rajeev M Dhere
Sambhaji S Pisal
Original Assignee
Serum Inst India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43356831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0915696(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serum Inst India Ltd filed Critical Serum Inst India Ltd
Publication of BRPI0915696A2 publication Critical patent/BRPI0915696A2/pt
Publication of BRPI0915696B1 publication Critical patent/BRPI0915696B1/pt
Publication of BRPI0915696B8 publication Critical patent/BRPI0915696B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12351—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BRPI0915696A 2008-11-07 2009-11-06 composição de vacina de rotavírus liofilizada e método de preparar a referida composição BRPI0915696B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2365MU2008 2008-11-07
IN2365/MUM/2008 2008-11-07
PCT/IN2009/000629 WO2010146598A2 (en) 2008-11-07 2009-11-06 Stable, dried rotavirus vaccine, compositions and process for preparation thereof

Publications (3)

Publication Number Publication Date
BRPI0915696A2 true BRPI0915696A2 (pt) 2016-02-10
BRPI0915696B1 BRPI0915696B1 (pt) 2020-06-23
BRPI0915696B8 BRPI0915696B8 (pt) 2021-05-25

Family

ID=43356831

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915696A BRPI0915696B8 (pt) 2008-11-07 2009-11-06 composição de vacina de rotavírus liofilizada e método de preparar a referida composição

Country Status (4)

Country Link
US (1) US8795686B2 (pt)
CN (1) CN102202688B (pt)
BR (1) BRPI0915696B8 (pt)
WO (1) WO2010146598A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2795047C (en) 2010-03-31 2019-04-09 Stabilitech Ltd. Stabilised liquid formulations
EP2898890B1 (en) 2010-03-31 2019-08-21 Stabilitech Biopharma Ltd Stabilisation of viral particles
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
AR099470A1 (es) * 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
SG11201610921PA (en) * 2014-07-18 2017-02-27 Msd Wellcome Trust Hilleman Lab Pvt Ltd A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof
JP6674944B2 (ja) * 2014-07-18 2020-04-01 エムエスディー ウェルカム トラスト ヒルマン ラボラトリーズ プライベート リミテッドＭｓｄ Ｗｅｌｌｃｏｍｅ Ｔｒｕｓｔ Ｈｉｌｌｅｍａｎ Ｌａｂｏｒａｔｏｒｉｅｓ Ｐｖｔ．Ｌｔｄ． 改善された耐熱性噴霧乾燥ロタウイルスワクチン製剤及びその製造方法
CN113730564A (zh) * 2014-12-08 2021-12-03 武汉生物制品研究所有限责任公司 口服六价重配轮状病毒活疫苗
CN104984357B (zh) * 2015-06-02 2018-01-30 长春百克生物科技股份公司 不含明胶的疫苗保护剂组合物及流感减毒活疫苗
CN106063933B (zh) * 2015-12-31 2020-01-07 武汉博沃生物科技有限公司 通用疫苗冻干保护剂及其应用
CA3048313A1 (en) 2017-01-06 2018-07-12 Stabilitech Biopharma Ltd Virus
US11110163B2 (en) 2017-02-14 2021-09-07 Inventprise, Llc Heat stable vaccines
KR102722153B1 (ko) 2017-02-14 2024-10-24 인벤트프라이즈 인크. 열 안정성 액체 로타바이러스 백신
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
US11179339B2 (en) 2017-09-19 2021-11-23 Advaxis, Inc. Compositions and methods for lyophilization of bacteria or listeria strains
PE20210106A1 (es) * 2017-10-16 2021-01-19 Serum Institute Of India Pvt Ltd Composiciones de vacuna estables que comprenden inter alia un flavivirus recombinante vivo atenuado y proceso para la preparacion de las mismas
CN107744504A (zh) * 2017-10-31 2018-03-02 山东亦度生物技术有限公司 一种ma104细胞制备人用轮状病毒活疫苗的冻干工艺方法
CN111150849A (zh) * 2020-04-02 2020-05-15 广州隽沐生物科技股份有限公司 一种组合物及其制备方法及其应用
CN115531363B (zh) * 2021-06-30 2024-03-29 中国科学技术大学 预防、抑制或治疗轮状病毒感染的药物组合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403098B1 (en) * 1996-09-26 2002-06-11 Merck & Co., Inc. Rotavirus vaccine formulations
US7951383B2 (en) * 1997-05-23 2011-05-31 The United States Of America As Represented By The Department Of Health And Human Services Attenuated parainfluenza virus (PIV) vaccines
WO2002009749A2 (en) * 2000-07-31 2002-02-07 Aventis Pasteur Limited Respiratory syncytial virus vaccine
US20030092145A1 (en) * 2000-08-24 2003-05-15 Vic Jira Viral vaccine composition, process, and methods of use
WO2003026642A1 (en) * 2001-09-21 2003-04-03 Sumitomo Pharmaceuticals Co., Ltd. Freeze-dried pharmaceutical preparation
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
ES2423663T3 (es) * 2005-08-08 2013-09-23 Oregon Health And Science University Inactivación de patógenos con peróxido de hidrógeno para la producción de vacunas

Also Published As

Publication number Publication date
CN102202688B (zh) 2017-04-12
CN102202688A (zh) 2011-09-28
WO2010146598A2 (en) 2010-12-23
US8795686B2 (en) 2014-08-05
WO2010146598A3 (en) 2011-06-30
US20110177119A1 (en) 2011-07-21
BRPI0915696B8 (pt) 2021-05-25
BRPI0915696B1 (pt) 2020-06-23

Similar Documents

Publication Publication Date Title
BRPI0915696A2 (pt) vacina de rotavírus estável, secada, composições e processo para preparação da mesma
BRPI0810763A2 (pt) Composição aglutinante betuminosa e processo para preparação da mesma
BRPI0819182A2 (pt) Polímero, proceso para preparar o mesmo, derivados, e, processo para preparar os mesmos
BRPI0812054A2 (pt) Processo para preparar compostos, e, compostos.
BRPI1014606A2 (pt) Maltotriosil transferase, processo para produção e uso da mesma
BRPI0814611A2 (pt) Composição, processo para preparar uma composição, e, uso de uma composição
BRPI0809600A2 (pt) vírus atenuado útil para vacinas
BRPI0909691A2 (pt) Composto, método para preparar um composto, e, composição farmacêutica
BRPI0924427A2 (pt) composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma
BRPI0816991A2 (pt) Formulação, processo para preparar a mesma, e, usos de uma composição antimicrobiana e de uma formulação
BRPI0721404A2 (pt) Moldagem, composição de moldagem, processo para produção de moldagens e uso da mesma
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BRPI0813644A2 (pt) Composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina
BRPI1012890A2 (pt) composição adjuvante aquosa, composição imunogênica, processo para preparar uma composição imunogênica, e, kit
BRPI0908352A2 (pt) Processo para produzir estruturas porosas, estrutura porosa, e, uso da mesma
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI1011888A2 (pt) processo para preparar um composto, e, composição.
BRPI0909198A2 (pt) composto antifolato, composto, método para preparar um composto antifolato, composição farmacêutica, método para tratar
BRPI0911898A2 (pt) processo para preparar compostos, e, composto.
BRPI0813690A2 (pt) Processo aperfeiçoado para preparar continuamente copolímeros de composição variável
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BRPI1008987A2 (pt) processo para preparar 3,3,3-trifluoropropeno
BRPI0909280A2 (pt) processo para preparar uretanos.
BRPI1010707A2 (pt) composição farmacêutica, processo para o preparo da mesma, processo para o preparo de uma formulação injetável e formulação injetável
BR112012001462A2 (pt) processo para preparar metil mercaptano.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B25D Requested change of name of applicant approved

Owner name: SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/06/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/11/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF